Rapid Legal Finance Offers Cash Advances on AstraZeneca/Seroquel Cases
Today, for many people, psychiatric drugs have become a popular solution to what ails them emotionally. Stress is at an all-time high, and these drugs seem to be a workable answer to handling it. Sadly, when misdiagnosed, the drugs don’t actually solve the underlying problem for the patient; they only cover it up by deadening the mind’s perceptions and in many cases causing a new set of health problems for the patient.
But the FDA has chimed and set some recent regulations that may help. For example, in early 2009 then ruled that AstraZeneca cannot market Seroquel for depression.
AstraZeneca faces personal-injury claims from about 15,000 people who took Seroquel and say it caused diabetes. They allege the company failed to adequately warn patients about Seroquel side effects like severe weight gain, diabetes and pancreatitis. Read more of the story here.
Rapid Legal Finance offers lawsuit cash advances to plaintiffs who have been misdiagnosed and prescribed Seroquel and other psychiatric drugs.
Currently, we are able to offer funding for any Seroquel cases. Just give us a call and let us know whether you have your award letter already or if you are waiting for it. We can help!
Rapid Legal Finance is now offering cash advances to plaintiffs who are part of a class action pharmaceutical case. If you have a class-action pharmaceutical case has already been settled, the process is very quick. We advance funds on Avandia, Accutane, Yasmin/Yaz, Miraplex, Gadolinium, Fossamax and Seroquel cases.